Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Lewis, Patrick Bowler (2009)
Botulinum toxin cosmetic therapy correlates with a more positive moodJournal of Cosmetic Dermatology, 8
Michael Gart, K. Gutowski (2016)
Overview of Botulinum Toxins for Aesthetic Uses.Clinics in plastic surgery, 43 3
M. Hur, Ho‐Jeong Kim, B. Choi, K. Hu, Hee-Jin Kim, Kyu‐Seok Lee (2013)
Morphology of the Mentalis Muscle and Its Relationship With the Orbicularis Oris and Incisivus Labii Inferioris MusclesJournal of Craniofacial Surgery, 24
J. Carruthers, A. Carruthers (2003)
Aesthetic Botulinum A Toxin in the Mid and Lower Face and NeckDermatologic Surgery, 29
B. Molina, Y. Grangier, B. Môle, N. Ribé, L. Díaz, W. Prager, F. Paliargues, N. Kerrouche (2015)
Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi‐centre European observational studyJournal of the European Academy of Dermatology and Venereology, 29
J. Jankovic, M. Brin (1991)
Therapeutic uses of botulinum toxin.The New England journal of medicine, 324 17
F. Ghalamkarpour, R. Robati, F. Aryanejad, P. Toossi (2010)
Supraciliary wrinkles and botulinum toxin AClinical and Experimental Dermatology, 35
E. Stanley, D. Drachman (1983)
Botulinum toxin blocks quantal but not non-quantal release of ACh at the neuromuscular junctionBrain Research, 261
K. Foster (2014)
Clinical Applications of Botulinum Neurotoxin
(2007)
Botulinum toxin AReactions Weekly, 1163
Y. Kuo, Yu-Ting Huang, Chun‐Ting Wang, Ching‐Jen Wang (2015)
Proteome Analysis the Differences of the Mesenchymal Stem Cells and Extracorporeal Shock Wave Therapy Enhancing Diabetic Wound Healing.Plastic and reconstructive surgery, 136 4 Suppl
A. Cansanção, A. Cansanção, Bethania Cansanção, Rafael Vidigal (2015)
Effect of Tranexamic Acid in Bleeding Control in Liposuction.Plastic and reconstructive surgery, 136 4 Suppl
S. Fagien, J. Carruthers (2008)
A Comprehensive Review of Patient-Reported Satisfaction with Botulinum Toxin Type A for Aesthetic ProceduresPlastic and Reconstructive Surgery, 122
P. Levy (2015)
Neurotoxins: Current Concepts in Cosmetic Use on the Face and Neck—Jawline Contouring/Platysma Bands/Necklace LinesPlastic and Reconstructive Surgery, 136
Rod Rohrich, J. Rios, Paul Smith, K. Gutowski (2006)
Neck Rejuvenation RevisitedPlastic and Reconstructive Surgery, 118
S. Liew, A. Dart (2008)
Nonsurgical reshaping of the lower face.Aesthetic surgery journal, 28 3
J. Carruthers, S. Fagien, S. Matarasso (2004)
Consensus recommendations on the use of botulinum toxin type a in facial aesthetics.Plastic and reconstructive surgery, 114 6 Suppl
Magnus Magnusson (1956)
ForwordBiological Psychiatry, 55
R. Pamphlett (1989)
Early terminal and nodal sprouting of motor axons after botulinum toxinJournal of the Neurological Sciences, 92
Jae Lee, J. Park, Soo Lee, K. Han, S. Kim, C. Yoon, Jaeyeo Park, Joo Lee, J. Yang, J. Lee (2014)
Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin AJournal of Dermatological Treatment, 25
The demand for non-surgical facial rejuvenation procedures is rising, and they are more popular than ever, with the aesthetic uses of botulinum toxin dramatically changing the landscape of facial rejuvenation. Botulinum toxin is a neurotoxin that works within cholinergic synapses present at neuromuscular endplates, preventing the transmission of neurotransmitters, such as acetylcholine, from nerves to muscles. This interference with nerve impulses leads to the muscles being temporarily weakened (paralysis). Botulinum toxin A was approved by the US Food and Drug Administration (FDA) for use in the glabella in 2002, followed by crow's feet in 2013 and then the forehead in 2017, with other aesthetic uses being classed as off-license. Botulinum toxin A yields good results in carefully selected patients, and a thorough consultation should always take place. Consultations should include management of expectations and the explanation that botulinum toxin A works on dynamic lines, rather than static lines. Treatment areas can be split into the upper face (glabellar, transverse forehead lines and lateral orbicularis oculi); mid face (bunny lines and perioral vertical lip lines); and lower face (masseter hypertrophy, mentalis, platysmal bands and gummy smile). Each patient should be assessed individually to determine individual anatomy, including the size, strength and location of muscles, with doses being adjusted accordingly.
Journal of Aesthetic Nursing – Mark Allen Group
Published: Dec 2, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.